secwatch.observer — SEC 8-K summary
======================================

Issuer:     PaxMedica, Inc. (—)
CIK:        0001811623
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001641172-25-015067
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PaxMedica cancels all outstanding shares, deregisters with SEC
--------------------------------------------------------------

- Company changed name to Kuvatris Therapeutics; all outstanding shares declared null, void, and worthless.
- Shares held by DTC and record shareholders ordered cancelled; beneficial shareholders left with worthless equity.
- Company to file Form 15-12g terminating SEC registration, ending all reporting obligations under Exchange Act.
- CEO Howard Weisman executed name change on June 6, 2025; share cancellation letter sent to DTC on May 20.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811623/000164117225015067/0001641172-25-015067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811623/000164117225015067/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-015067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer